{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:09:12Z","timestamp":1790665752990,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bbadis.2020.166010","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T16:04:29Z","timestamp":1605110669000},"page":"166010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator"],"prefix":"10.1016","volume":"1867","author":[{"given":"Marie-Laure","family":"Jourdain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Sergheraert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Braux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie C.","family":"Gangloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Velard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Jacquot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10059","key":"10.1016\/j.bbadis.2020.166010_bb0005","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"issue":"9678","key":"10.1016\/j.bbadis.2020.166010_bb0010","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O\u2019Sullivan","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbadis.2020.166010_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17476348.2019.1552832","article-title":"Acute and chronic non-pulmonary complications in adults with cystic fibrosis","volume":"13","author":"Regard","year":"2019","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"10.1016\/j.bbadis.2020.166010_bb0020","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bbadis.2020.166010_bb0025","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1164\/rccm.200206-578OC","article-title":"Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis","volume":"166","author":"Elkin","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbadis.2020.166010_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bone.2017.02.007","article-title":"Impaired rib bone mass and quality in end-stage cystic fibrosis patients","volume":"98","author":"Mailhot","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bbadis.2020.166010_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bone.2016.04.030","article-title":"Trabecular and cortical bone deficits are present in children and adolescents with cystic fibrosis","volume":"90","author":"Kelly","year":"2016","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bbadis.2020.166010_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191013","article-title":"Peripheral quantitative computed tomography detects differences at the radius in prepubertal children with cystic fibrosis compared to healthy controls","volume":"13","author":"O\u2019Brien","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbadis.2020.166010_bb0045","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1164\/rccm.200606-776OC","article-title":"Low bone mineral density in young children with cystic fibrosis","volume":"175","author":"Sermet-Gaudelus","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbadis.2020.166010_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bone.2017.11.006","article-title":"Adults with cystic fibrosis have deficits in bone structure and strength at the distal tibia despite similar size and measuring standard and relative sites","volume":"107","author":"Nishiyama","year":"2018","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bbadis.2020.166010_bb0055","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-128-3-199802010-00004","article-title":"Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis","volume":"128","author":"Aris","year":"1998","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.bbadis.2020.166010_bb0060","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1164\/rccm.201803-0415LE","article-title":"Overexpression of RANK and M-CSFR in monocytes of G551D-bearing patients with cystic fibrosis","volume":"198","author":"Velard","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.bbadis.2020.166010_bb0065","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-015-3343-3","article-title":"Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies","volume":"27","author":"Jacquot","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bbadis.2020.166010_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1183\/09031936.04.00050204","article-title":"Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor","volume":"25","author":"King","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbadis.2020.166010_bb0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/bonekey.2013.215","article-title":"Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit","volume":"3","author":"Sims","year":"2014","journal-title":"Bonekey Rep"},{"issue":"2","key":"10.1016\/j.bbadis.2020.166010_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat. Med."},{"issue":"52","key":"10.1016\/j.bbadis.2020.166010_bb0085","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0805133106","article-title":"Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate","volume":"105","author":"Pederson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2020.166010_bb0090","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/ncomms6215","article-title":"Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts","volume":"5","author":"Keller","year":"2014","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbadis.2020.166010_bb0095","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41591-018-0005-y","article-title":"Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss","volume":"24","author":"Weske","year":"2018","journal-title":"Nat. Med."},{"issue":"24","key":"10.1016\/j.bbadis.2020.166010_bb0100","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1038\/sj.emboj.7601430","article-title":"Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling","volume":"25","author":"Ryu","year":"2006","journal-title":"EMBO J."},{"issue":"7237","key":"10.1016\/j.bbadis.2020.166010_bb0105","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature07713","article-title":"Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis","volume":"458","author":"Ishii","year":"2009","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbadis.2020.166010_bb0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/14728222.2017.1332180","article-title":"Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential","volume":"21","author":"Meshcheryakova","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"8","key":"10.1016\/j.bbadis.2020.166010_bb0115","doi-asserted-by":"crossref","first-page":"E1421","DOI":"10.1210\/jc.2012-1044","article-title":"Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans","volume":"97","author":"Lee","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bbadis.2020.166010_bb0120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/cyto.a.22456","article-title":"Detection of CFTR protein in human leukocytes by flow cytometry","volume":"85","author":"Johansson","year":"2014","journal-title":"Cytometry A"},{"issue":"10","key":"10.1016\/j.bbadis.2020.166010_bb0125","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1164\/rccm.201510-1922OC","article-title":"Mutations of cystic fibrosis transmembrane conductance regulator gene cause a monocyte-selective adhesion deficiency","volume":"193","author":"Sorio","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.bbadis.2020.166010_bb0130","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/thx.2006.075887","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone","volume":"62","author":"Shead","year":"2007","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.bbadis.2020.166010_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130313","article-title":"Sphingosine-1-phosphate is a novel regulator of cystic fibrosis transmembrane conductance regulator (CFTR) activity","volume":"10","author":"Malik","year":"2015","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.bbadis.2020.166010_bb0140","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.111.047316","article-title":"Tumor necrosis factor-alpha-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure","volume":"125","author":"Meissner","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bbadis.2020.166010_bb0145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/jbmr.070109","article-title":"Are nonresorbing osteoclasts sources of bone anabolic activity?","volume":"22","author":"Karsdal","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bbadis.2020.166010_bb0150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S2213-2600(12)70057-7","article-title":"A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect","volume":"1","author":"Boyle","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.bbadis.2020.166010_bb0155","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ajpath.2013.12.027","article-title":"Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis","volume":"184","author":"Le Henaff","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bbadis.2020.166010_bb0160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/path.4753","article-title":"Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis","volume":"240","author":"Delion","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2020.166010_bb0165","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fimmu.2018.00632","article-title":"An optimized method to generate human active osteoclasts from peripheral blood monocytes","volume":"9","author":"Abdallah","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2020.166010_bb0170","doi-asserted-by":"crossref","first-page":"15032","DOI":"10.1038\/boneres.2015.32","article-title":"Pit- and trench-forming osteoclasts: a distinction that matters","volume":"3","author":"Merrild","year":"2015","journal-title":"Bone Res"},{"key":"10.1016\/j.bbadis.2020.166010_bb0175","first-page":"187","article-title":"Fluorescent indicator methods to assay functional CFTR expression in cells","volume":"70","author":"Verkman","year":"2002","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.bbadis.2020.166010_bb0180","first-page":"926045","article-title":"A roadmap to the brittle bones of cystic fibrosis","volume":"2011","author":"Gore","year":"2010","journal-title":"J. Osteoporos."},{"issue":"5","key":"10.1016\/j.bbadis.2020.166010_bb0185","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.ajpath.2012.01.039","article-title":"The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation","volume":"180","author":"Le Henaff","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bbadis.2020.166010_bb0190","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1183\/09031936.99.14247899","article-title":"Hip fracture and bone histomorphometry in a young adult with cystic fibrosis","volume":"14","author":"Haworth","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.bbadis.2020.166010_bb0195","first-page":"666","article-title":"Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation","volume":"123","author":"Lotinun","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2020.166010_bb0200","first-page":"423","article-title":"Understanding the local actions of lipids in bone physiology","volume":"41","author":"During","year":"2015","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.bbadis.2020.166010_bb0205","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm1748","article-title":"Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis","volume":"14","author":"Teichgraber","year":"2008","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2020.166010_bb0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.plefa.2010.07.002","article-title":"Fatty acid metabolism in cystic fibrosis","volume":"83","author":"Strandvik","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"25","key":"10.1016\/j.bbadis.2020.166010_bb0215","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1016\/j.biomaterials.2010.04.061","article-title":"The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720","volume":"31","author":"Petrie Aronin","year":"2010","journal-title":"Biomaterials"},{"issue":"38","key":"10.1016\/j.bbadis.2020.166010_bb0220","doi-asserted-by":"crossref","first-page":"35258","DOI":"10.1074\/jbc.M105442200","article-title":"Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate","volume":"276","author":"Boujaoude","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbadis.2020.166010_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008007","article-title":"Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci","volume":"15","author":"Gong","year":"2019","journal-title":"PLoS Genet."},{"issue":"17","key":"10.1016\/j.bbadis.2020.166010_bb0230","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1807119","article-title":"VX-659-Tezacaftor-Ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Davies","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.bbadis.2020.166010_bb0235","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2020.166010_bb0240","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2020.166010_bb0245","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.jcf.2016.09.003","article-title":"Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation","volume":"15","author":"Sermet-Gaudelus","year":"2016","journal-title":"J. Cyst. Fibros."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443920303586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443920303586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:59:32Z","timestamp":1760417972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443920303586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0925443920303586"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2020.166010","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2020.166010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166010"}}